Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
May 31, 2020
May 31, 2019
Income Statement [Abstract]    
Revenue $ 0 $ 0
Expenses    
Research and development, net (Note 13) 1,480,588 997,861
General and administrative (Note 13) 1,953,081 1,902,630
Depreciation and amortization (Notes 5 and 6) 255,974 164,336
Interest and other financial expenses (Note 16) 126,776 501,849
Interest income (40,346) 0
Foreign exchange loss (gain) 76,641 (12,126)
Total expenses 3,852,714 3,554,550
Net loss (3,852,714) (3,554,550)
Other comprehensive loss    
Foreign currency translation adjustment (170,412) (140,142)
Comprehensive loss $ (4,023,126) $ (3,694,692)
Loss per share    
Basic and diluted $ (0.10) $ (0.11)
Weighted average common shares outstanding    
Basic and diluted 39,916,838 34,714,510